Other Information.
+Added: On October 2, 2023, we previously announced the resignation of our former Chief Medical Officer, Cadmus Rich, M.D., effective as of October 16, 2023, at which time he transitioned into the role of Senior Clinical Advisor until November 7, 2023, or the Departure Date.
+Added: In connection with Dr.
+Added: Rich’s resignation, on November 6, 2023, we and Dr.
+Added: Rich entered into a Transition and Release Agreement, or the Transition Agreement, which became effective on November 7, 2023 and will supersede the Transition Agreement previously entered into on September 26, 2023.
+Added: The Transition Agreement provides that Dr.
+Added: Rich will receive continued salary through the Departure Date subject to Dr.
+Added: Rich’s performance of certain Transition Services (as defined in the Transition Agreement).
+Added: Subject to entering into a release of claims in favor of the Company, Dr.
+Added: Rich will be entitled to receive (i) severance pay equal to continuation of his annual base salary for nine months and (ii) subject to Dr.
+Added: Rich’s timely election to continue COBRA health coverage and copayment of premium amounts at the applicable active employees’
+Added: rate, a monthly cash payment equal to the amount that we would have paid to provide health insurance to Dr.
+Added: Rich until the earlier of nine months, eligibility for medical care coverage through other employment or termination of eligibility under COBRA.
+Added: Any continued vesting relating to Dr.
+Added: Rich’s existing equity awards would be subject, upon the Departure Date, to his entry into a consulting agreement.
+Added: The Transition Agreement also includes customary confidentiality and non-disparagement provisions.
Tenth Amended and Restated Certificate of Incorporation of Registrant, as currently in effect (incorporated by reference to Exhibit 3.1 of the Registrants’
5 unchanged sentences
333-260156)).
+Added: Employment Offer Letter, dated August 9, 2023, by and between Jill Hopkins and the Registrant.
+Added: Transition and Release Agreement, dated September 28, 2023, by and between Cadmus Rich and the Registrant.
+Added: Consulting Agreement, dated September 28, 2023, by and between Cadmus Rich and the Registrant.
+Added: Transition and Release Agreement, dated November 6, 2023, by and between Cadmus Rich and the Registrant.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
11 unchanged sentences
* Filed herewith.
+Added: Indicates a management contract or any compensatory plan, contract or arrangement.
# These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
+Added: (1) Schedules and exhibits have been omitted from this filing pursuant to Item 601(b)(10) of Regulation S-K.
+Added: The registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon its request;
+Added: provided, however, that the registrant may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any schedule or exhibit so furnished.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Aura Biosciences, Inc.
−Removed: August 9, 2023
+Added: November 9, 2023
/s/ Elisabet de los Pinos
1 unchanged sentence
President and Chief Executive Officer
−Removed: August 9, 2023
+Added: November 9, 2023
/s/ Julie Feder
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.